Jamjoom Pharmaceuticals Factory Company (TADAWUL: 4015)

Jamjoom Pharmaceuticals Factory Company Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 12, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12,824	8,050	-	-	-	-
Enterprise Value	12,665	7,954	-	-	-	-
Last Close Price	183.20	112.65	-	-	-	-
PE Ratio	38.67	26.97	-	-	-	-
PS Ratio	10.40	7.31	-	-	-	-
PB Ratio	8.76	5.73	-	-	-	-
P/FCF Ratio	63.73	32.09	-	-	-	-
P/OCF Ratio	38.61	27.19	-	-	-	-
EV/Sales Ratio	10.27	7.23	-	-	-	-
EV/EBITDA Ratio	31.69	23.27	-	-	-	-
EV/EBIT Ratio	34.34	25.18	-	-	-	-
EV/FCF Ratio	62.94	31.71	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.08	0.03
Debt / EBITDA Ratio	0.01	0.01	0.01	0.01	0.34	0.17
Debt / FCF Ratio	0.01	0.01	0.02	0.02	0.86	0.27
Asset Turnover	0.72	0.72	0.65	0.50	0.58	0.59
Inventory Turnover	2.34	2.18	2.44	1.97	2.99	2.91
Quick Ratio	2.88	3.58	4.16	3.90	2.90	4.80
Current Ratio	3.94	5.04	5.42	5.06	3.54	5.65
Return on Equity (ROE)	23.54%	22.32%	14.00%	14.16%	18.40%	15.17%
Return on Assets (ROA)	13.11%	12.90%	10.67%	7.93%	10.79%	8.76%
Return on Capital (ROIC)	15.95%	15.04%	12.36%	9.25%	12.59%	10.14%
Earnings Yield	2.59%	3.63%	-	-	-	-
FCF Yield	1.57%	3.12%	-	-	-	-
Dividend Yield	1.75%	2.22%	-	-	-	-
Payout Ratio	52.77%	23.94%	86.85%	66.40%	43.83%	54.80%
Buyback Yield / Dilution	-	-600.00%	-	-	-
Total Shareholder Return	1.75%	2.22%	-600.00%	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.